• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CUV 0.33% $15.16

CLINUVEL PHARMACEUTICALS LIMITED

Clinuvel Pharmaceuticals Limited is a global specialty pharmaceutical company. The... Clinuvel Pharmaceuticals Limited is a global specialty pharmaceutical company. The Company is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. The Company is engaged in managing and expanding commercial distribution of its lead drug candidate, SCENESSE, in Europe, the United States, Israel, and Australia for the treatment of a rare, genetic metabolic disorder, erythropoietic protoporphyria (EPP). The Company’s pipeline includes PRENUMBRA, NEURACTHEL, CUV9900, and Parvysmelanotide (VLRX001). PRENUMBRA is a liquid (non-solid) injectable formulation of afamelanotide designed to provide a flexible dose of afamelanotide, a synthetic analogue of natural a-melanocyte stimulating hormone. NEURACTHEL is a novel formulation of the melanocortin adrenocorticotropic hormone (ACTH), for neurological, endocrinological and degenerative disorders.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CUV 16:21 19 6.7K
16:21 Last post  J_Bee Comments Created with Sketch.  19  Views Created with Sketch.  6.7K 
CUV
What is an acceptable price target by the 2024 AGM?
11:59 2 546
11:59 Last post  Imac4 Comments Created with Sketch.  2  Views Created with Sketch.  546 
CUV 08:10 2 830
TRENDING NEWS

SS1: a 292,000,000 silver equivalent resource commences trading on the ASX at 11am AEST 15th May 2024

NEWS
13 May 2024
08:10 Last post  WickedKitty Comments Created with Sketch.  2  Views Created with Sketch.  830 
CUV
CUV - Technical Anslysis Discussion
12/05/24 0 221
12/05/24 Last post  Asxcharts Comments Created with Sketch.  0  Views Created with Sketch.  221 
CUV
CUV9900 - The sleeping giant is waking up!!
09/05/24 12 9.2K
09/05/24 Last post  trent3727 Comments Created with Sketch.  12  Views Created with Sketch.  9.2K 
CUV 09/05/24 2 694
09/05/24 Last post  sydneybhai Comments Created with Sketch.  2  Views Created with Sketch.  694 
CUV 06/05/24 6 2.2K
06/05/24 Last post  trent3727 Comments Created with Sketch.  6  Views Created with Sketch.  2.2K 
CUV
Disc Medicine - Best comparison stock to Clinuvel
2
04/05/24 103 39K
04/05/24 Last post  J_Bee Comments Created with Sketch.  103  Views Created with Sketch.  39K 

See All Discussions arrow Created with Sketch.

Timeline

Update - Notification of buy-back - CUV
10 May 09:08
 
Update - Notification of buy-back - CUV
09 May 09:13
 
Update - Notification of buy-back - CUV
06 May 09:18
 
Update - Notification of buy-back - CUV
03 May 09:01
 
Syd Capital Markets Briefing Presentation
01 May 09:18
 
SCENESSE European Orphan Drug Designation for XP
29 Apr 09:24
 
View More arrow Created with Sketch.
(20min delay)
Last
$15.16
Change
-0.050(0.33%)
Mkt cap ! $759.5M
Open High Low Value Volume
$15.20 $15.21 $14.90 $606.6K 40.13K

Buyers (Bids)

No. Vol. Price($)
1 150 $15.15
 

Sellers (Offers)

Price($) Vol. No.
$15.20 860 1
View Market Depth
Last trade - 16.10pm 13/05/2024 (20 minute delay) ?
Last
$15.14
  Change
-0.050 ( 0.16 %)
Open High Low Volume
$15.11 $15.21 $14.95 4220
Last updated 15.59pm 13/05/2024 ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.